Clinical Trial Update: Intraperitoneal PX in Combination With Nab-Paclitaxel in Patients With Peritoneal Metastatic Mucinous Adenocarcinoma [Phase 1]

View source ↗

Summary

Phase 1 clinical trial investigating intraperitoneal PX with nab-paclitaxel for peritoneal metastatic cancer; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peritoneal Cancer
• Peritoneal Metastasis

Drugs mentioned

• Nab-paclitaxel (paclitaxel protein-bound)
• PX

Snippet

Sponsor: Peking University | Conditions: Peritoneal (Metastatic) Cancer | Phase 1 | Status: NOT_YET_RECRUITING